Enhancing Virus-Specific Immunity In Vivo by Combining Therapeutic Vaccination and PD-L1 Blockade in Chronic Hepadnaviral Infection-Reference-Cited by-同舟云学术

Enhancing Virus-Specific Immunity In Vivo by Combining Therapeutic Vaccination and PD-L1 Blockade in Chronic Hepadnaviral Infection

Published:2014-01-02 Issue:1 Volume:10 Page:e1003856
ISSN:1553-7374
Container-title:PLoS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Liu Jia,Zhang Ejuan,Ma Zhiyong,Wu Weimin,Kosinska Anna,Zhang Xiaoyong,Möller Inga,Seiz Pia,Glebe Dieter,Wang Baoju,Yang Dongliang,Lu Mengji,Roggendorf Michael

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference53 articles.

1. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial;HL Janssen;Lancet,2005

2. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B;GK Lau;N Engl J Med,2005

3. Cellular and virological mechanisms of HBV drug resistance;S Locarnini;J Hepatol,2006

4. Hepatitis B virus resistance to nucleos(t)ide analogues;F Zoulim;Gastroenterology,2009

5. T cells and viral persistence: lessons from diverse infections;P Klenerman;Nat Immunol,2005

Cited by 229 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors in infectious disease;Immunological Reviews;2024-09-09

2. Discontinuation of Nucleos(t)ide Analogues in HBeAg Negative Chronic Hepatitis B Patients: Risks and Benefits;Infectious Diseases and Clinical Microbiology;2024-06-28

3. The role of immune checkpoint inhibitors in the development and treatment of infectious processes;Journal of Clinical Practice;2024-04-17

4. Elimination of the hepatitis B virus: A goal, a challenge;Medicinal Research Reviews;2024-03-25

5. Path to Cure Hepatitis B: How Far Are We?;Livestock Diseases and Management;2024